Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases

On July 11, 2019, the U.S. Department of Justice announced that Reckitt Benckiser Group PLC agreed to pay $1.4 billion to resolve possible criminal and civil liability related to allegations involving the sale of the opioid addiction treatment drug Suboxone.

We represent one of the individuals who blew the whistle on Reckitt and helped bring this case to the government’s attention.